These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18358571)

  • 21. 1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors.
    Hequet A; Burchak ON; Jeanty M; Guinchard X; Le Pihive E; Maigre L; Bouhours P; Schneider D; Maurin M; Paris JM; Denis JN; Jolivalt C
    ChemMedChem; 2014 Jul; 9(7):1534-45. PubMed ID: 24677763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
    Fontaine F; Hequet A; Voisin-Chiret AS; Bouillon A; Lesnard A; Cresteil T; Jolivalt C; Rault S
    J Med Chem; 2014 Mar; 57(6):2536-48. PubMed ID: 24499135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyacylated oligosaccharides from medicinal Mexican morning glory species as antibacterials and inhibitors of multidrug resistance in Staphylococcus aureus.
    Pereda-Miranda R; Kaatz GW; Gibbons S
    J Nat Prod; 2006 Mar; 69(3):406-9. PubMed ID: 16562846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria.
    Lomovskaya O; Watkins W
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):225-36. PubMed ID: 11321578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of PSSRI-based inhibitors of Staphylococcus aureus multidrug efflux pumps.
    German N; Kaatz GW; Kerns RJ
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1368-73. PubMed ID: 18242086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In search of natural substrates and inhibitors of MDR pumps.
    Lewis K
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):247-54. PubMed ID: 11321580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NorA, Tet(K), MepA, and MsrA Efflux Pumps in
    de Morais Oliveira-Tintino CD; Muniz DF; Dos Santos Barbosa CR; Silva Pereira RL; Begnini IM; Rebelo RA; da Silva LE; Mireski SL; Nasato MC; Lacowicz Krautler MI; Barros Oliveira CV; Pereira PS; Rodrigues Teixeira AM; Tintino SR; de Menezes IRA; Melo Coutinho HD; da Silva TG
    Curr Pharm Des; 2023; 29(5):323-355. PubMed ID: 36515045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy.
    Mahamoud A; Chevalier J; Alibert-Franco S; Kern WV; Pagès JM
    J Antimicrob Chemother; 2007 Jun; 59(6):1223-9. PubMed ID: 17229832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.
    Zheng J; Cui S; Meng J
    J Antimicrob Chemother; 2009 Jan; 63(1):95-102. PubMed ID: 18984645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-amino-3-methylpiperidin-1-yl)fluoroquinolone derivatives.
    Chai Y; Wan ZL; Wang B; Guo HY; Liu ML
    Eur J Med Chem; 2009 Oct; 44(10):4063-9. PubMed ID: 19481308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural differences between paroxetine and femoxetine responsible for differential inhibition of Staphylococcus aureus efflux pumps.
    Wei P; Kaatz GW; Kerns RJ
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3093-7. PubMed ID: 15149651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein.
    Kaatz GW; McAleese F; Seo SM
    Antimicrob Agents Chemother; 2005 May; 49(5):1857-64. PubMed ID: 15855507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles.
    Holler JG; Slotved HC; Mølgaard P; Olsen CE; Christensen SB
    Bioorg Med Chem; 2012 Jul; 20(14):4514-21. PubMed ID: 22682300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-caffeoylphenalkylamide derivatives as bacterial efflux pump inhibitors.
    Michalet S; Cartier G; David B; Mariotte AM; Dijoux-franca MG; Kaatz GW; Stavri M; Gibbons S
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1755-8. PubMed ID: 17275293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the effect of bacterial efflux pumps on the antibacterial activity of the novel fluoroquinolone besifloxacin.
    Shinabarger DL; Zurenko GE; Hesje CK; Sanfilippo CM; Morris TW; Haas W
    J Chemother; 2011 Apr; 23(2):80-6. PubMed ID: 21571623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efflux pump inhibitory potential of indole derivatives as an arsenal against
    Chandal N; Tambat R; Kalia R; Kumar G; Mahey N; Jachak S; Nandanwar H
    Microbiol Spectr; 2023 Sep; 11(5):e0487622. PubMed ID: 37754560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural Modifications of the Quinolin-4-yloxy Core to Obtain New
    Cannalire R; Mangiaterra G; Felicetti T; Astolfi A; Cedraro N; Massari S; Manfroni G; Tabarrini O; Vaiasicca S; Barreca ML; Cecchetti V; Biavasco F; Sabatini S
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimized efflux assay for the NorA multidrug efflux pump in Staphylococcus aureus.
    Zimmermann S; Tuchscherr L; Rödel J; Löffler B; Bohnert JA
    J Microbiol Methods; 2017 Nov; 142():39-40. PubMed ID: 28887002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
    Brincat JP; Carosati E; Sabatini S; Manfroni G; Fravolini A; Raygada JL; Patel D; Kaatz GW; Cruciani G
    J Med Chem; 2011 Jan; 54(1):354-65. PubMed ID: 21141825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position.
    Felicetti T; Cannalire R; Nizi MG; Tabarrini O; Massari S; Barreca ML; Manfroni G; Schindler BD; Cecchetti V; Kaatz GW; Sabatini S
    Eur J Med Chem; 2018 Jul; 155():428-433. PubMed ID: 29908437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.